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Indications and results of exercise testing in 110 patients
Hasnaa Salih [Orateur], Siham Jemali, Roger Kongo, Ahmed Bennis
CHU Ibn Rochd, Casablanca, Maroc
Introduction: Exercise testing(ET) remains the most widely accessible
and relatively inexpensive method for initial evaluation of suspected coronary
disease and for evaluation of its severity.
The aim of our study is to define the indications and the results of 110
exercice testing.
Material and Methods: We included all patients sent for ET in Ibn Rochd
Center of Cardiology from June 2010 to December 2010. Clinical, investiga-
tional and demographic data on all patients admitted were collected prospec-
tively. ET were done using the Bruce protocol.
Statistical analysis was performed on IBM SPSS Statistics 19.
Results: During the study, 110 patients underwent ET. The mean age was
49.3± 13.8 (range 6 to 78 years), with a female majority (54.1% vs 45.9%).
Hypertension and diabetes were the most frequently cardiovascular risk factor
(43.2%) followed by smoking (29.7%) and obesity (21%). Indications of ET
were: atypical chest pain in 54.1%;angina in 10.8%; assessment of diabetes in
10.8%; post-IDM in 13.5%; assessment of ventricular extrasystoles in 7.2%
and assessment of athletes in 3.6%. There were 81.1% negative, 13.5% posi-
tive and 5.4% indeterminate tests. The maximum heart rate achieved was 169
±13.8 beats/min (range 110 to 197), which was 93.7 ±10.1% of predicted
maximum (16.2% on beta-adrenergic blocking agents at ET). The mean of
exercise duration was 7.4± 1.8min. Reasons for termination were: tiredness in
54.1%; reaching predicted maximum heart rate in (37.8%); severe chest pain
in 5.4%, nonsustained ventricular tachycardia in 1.8%; and dyspnea in (0.9%).
Positive ST segment change were observed in (13.5%). 
Conclusion: Exercise testing (ET) stands as one of the most easy, afford-
able, cost effective, non invasive methods for diagnosing coronary heart dis-
ease. It continues to remain a valuable addition to the diagnostic means of
Cardiologists, not only for the first assessment of heart patients with CHD, but
also for providing information relevant to the extent of ischemic heart disease,
and the prognosis of these patients. 
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Purpose: Coronary artery disease is an emerging problem in developing
countries. In Djibouti, management of patients with acute ST elevation myo-
cardial infarction (STEMI) is particularly challenging without any access to
primary percutaneous coronary intervention (PCI). 
Methods: Management and outcome of patients hospitalized for acute
STEMI in the French Military Hospital in Djibouti were prospectively
recorded over a 2-year period (2009-2010). 
Results: 10900 patients were admitted in the emergency department and
STEMI was diagnosed in 35 cases (0.3%): 31 were males (89%), mean age was
51±11 years [29-76 years]. Cardiovascular risk factors (CVRF) were tobacco use
(60%), diabetes (49%), hypertension (46%), lipid abnormalities (83%), heredity
(20%). According to ECG pattern, STEMI was anterior in 14 cases (40%), inferior
in 13 (37%), lateral in 8 (23%). Delay between the onset of symptoms and diag-
nosis was <6 h in 12 patients and <12 h in 15 patients (40%). All these 15 patients
received single-bolus tenecteplase within 5.1±2.6 h after the onset of symptoms
with signs of reperfusion in 11 cases (73%) without complication. Seven patients
(20%) had the possibility to be sent abroad and underwent PCI within 3 days after
fibrinolysis. Five patients (14%) died within the first month and 7 (20%) at the end
of follow up (11.3 ± 9 months). Mortality was significantly associated with dia-
betes (p<0.01) and initial lower LVEF (mean LVEF 32% ± 9% in mortality group
vs 50 ± 7% in surviving patients p<0.00001). Successful fibrinolysis was associ-
ated with lower mortality (p<0.05). Khat chewing (57%) was not associated with
specific presentation, management or outcome.
Conclusion: Mortality related to STEMI was 3 times higher in this Djibou-
tian series than previously reported in series including patients undergoing
PCI. Fibrinolysis showed significant benefit but was performed in only 40%
of patients. Diabetes was associated with increased mortality but Khat
chewing was not. 
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Purpose: Collection of epidemiological data, analysis of medical proce-
dures, deadlines and evolution of acute coronary syndromes (ACS), are some
of the goals of our study.
Materials and methods: It is a retrospective descriptive study that
included patients admitted for ACS in the cardiology department of the Avi-
cenne military hospital in Marrakech between January 2006 and December
2009. Patients were investigated focusing in epidemiological analysis of car-
diovascular risk factors, an ECG, a biological assessment and a Doppler ultra-
sound cardiac examination (TTE). 
Results
The admission deadline is long with 43% of STEMI (ST elevation myocar-
dial infarction) beyond 12 hours. Overall mortality is 1,3%, mainly recorded
in STEMI. However, complications are more often (14%), and more than half
of them have a recurrent pain that occurred in less than 6 months.
Conclusion
Our results are epidemiologically comparable to different series. The inter-
national medical care recommendations are widely followed. But we need to
ACS 
with ST elevation
N= 40
ACS 
with non ST elevation
N= 39
Average age (years) 56±8 56±7
Sex ratio (Men/Women) 9/1 2/1
Smoking 68% 53,8%
Dyslipidemy 65% 66,7%
Diabetes 40% 53,8%
Hypertension 32,5% 30,8%
Anterior topography 73% 65%
Systolic dysfunction 62,5% 33,3%
Coronarography 47,5% 64%
Thrombolysis 27,5% –
Angioplasty 37,5% 28,2%
Aspirin 100% 97,4%
Clopidogrel 90% 70%
LMWH 77,5% 70%
UFH 22,5% –
ß blockers 90% 84,6%
Blockers of RA system 77,5% 66,7%
Statins 95% 87%
Anti GP 2b3a – 41%
LMWH: low molecular weight heparin; UFH: unfractionned heparin; 
RA: renin angiotensin 
